Aicardi syndrome: Difference between revisions
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Aicardi}} | |||
{{SI}} | |||
{{CMG}}; {{AE}} | |||
{{PleaseHelp}} | |||
{{DiseaseDisorder infobox | | {{DiseaseDisorder infobox | | ||
Name = Aicardi syndrome | | Name = Aicardi syndrome | | ||
Line 13: | Line 20: | ||
DiseasesDB = 29761 | | DiseasesDB = 29761 | | ||
}} | }} | ||
==Overview== | ==Overview== | ||
'''Aicardi syndrome''' is an uncommon [[congenital disorder|malformation syndrome]] characterized by absence of a key structure in the brain called the [[agenesis of the corpus callosum|corpus callosum]], the presence of retinal abnormalities, and [[seizures]] in the form of [[infantile spasms]]. Aicardi syndrome is inherited as an [[X-linked dominant]] trait that is lethal in males. | '''Aicardi syndrome''' is an uncommon [[congenital disorder|malformation syndrome]] characterized by absence of a key structure in the brain called the [[agenesis of the corpus callosum|corpus callosum]], the presence of retinal abnormalities, and [[seizures]] in the form of [[infantile spasms]]. Aicardi syndrome is inherited as an [[X-linked dominant]] trait that is lethal in males. | ||
== Historical Perspective == | ==Historical Perspective== | ||
This disorder was first recognized as a distinct syndrome in 1965 by Jean Aicardi, a French neurologist. A review article by Dr. Aicardi (Aicardi J, Aicardi syndrome: old and new findings, Int Pediatr. 1998;14(1):5-8) describes the syndrome. Aicardi syndrome should not be confused with Aicardi-Goutières syndrome, a distinct disorder. | This disorder was first recognized as a distinct syndrome in 1965 by Jean Aicardi, a French neurologist. A review article by Dr. Aicardi (Aicardi J, Aicardi syndrome: old and new findings, Int Pediatr. 1998;14(1):5-8) describes the syndrome. Aicardi syndrome should not be confused with Aicardi-Goutières syndrome, a distinct disorder. | ||
== | ==Classification== | ||
==Pathosphysiology== | ==Pathosphysiology== | ||
Line 34: | Line 37: | ||
All cases of Aicardi syndrome are thought to be due to new [[mutations]]. No person with Aicardi syndrome is known to have transmited the X-linked gene responsible for the syndrome to the next generation. | All cases of Aicardi syndrome are thought to be due to new [[mutations]]. No person with Aicardi syndrome is known to have transmited the X-linked gene responsible for the syndrome to the next generation. | ||
== Natural History, Complications, Prognosis == | ==Causes== | ||
==Differentiating {{PAGENAME}} from Other Diseases== | |||
==Epidemiology and Demographics== | |||
Around 500 cases of Aicardi syndrome have been reported worldwide. Except that the syndrome is fairly uncommon, its precise frequency in the population is unknown. Almost all reported cases of Aicardi syndrome have been in females. | |||
==Risk Factors== | |||
==Screening== | |||
==Natural History, Complications, Prognosis== | |||
Children are most commonly identified with Aicardi syndrome between the ages of three and five months. A significant number of these girls are products of normal births and seem to be developing normally until around the age of three months, when they begin to have infantile spasms. The onset of infantile spasms at this age is due to closure of the final neural synapses in the brain, a stage of normal [[brain development]]. | Children are most commonly identified with Aicardi syndrome between the ages of three and five months. A significant number of these girls are products of normal births and seem to be developing normally until around the age of three months, when they begin to have infantile spasms. The onset of infantile spasms at this age is due to closure of the final neural synapses in the brain, a stage of normal [[brain development]]. | ||
Line 41: | Line 55: | ||
The [[prognosis]] varies widely from case to case. However, all individuals reported with Aicardi syndrome to date have experienced developmental delay of a significant degree, typically resulting in moderate to profound [[mental retardation]]. The age range of the individuals reported with Aicardi syndrome is from birth to the mid 40’s. Aicardi syndrome appears to be lethal in normal males who have only one [[X chromosome]] (and a [[Y chromosome]]). | The [[prognosis]] varies widely from case to case. However, all individuals reported with Aicardi syndrome to date have experienced developmental delay of a significant degree, typically resulting in moderate to profound [[mental retardation]]. The age range of the individuals reported with Aicardi syndrome is from birth to the mid 40’s. Aicardi syndrome appears to be lethal in normal males who have only one [[X chromosome]] (and a [[Y chromosome]]). | ||
== Diagnosis == | ==Diagnosis== | ||
Aicardi syndrome is characterized by the following triad of features: | Aicardi syndrome is characterized by the following triad of features: | ||
Line 49: | Line 63: | ||
Other types of defects of the brain such as [[microcephaly]], [[porencephaly|porencephalic cyst]]s and enlarged [[Ventricular_system|cerebral ventricle]]s due to [[hydrocephalus]] are also more common in Aicardi syndrome. | Other types of defects of the brain such as [[microcephaly]], [[porencephaly|porencephalic cyst]]s and enlarged [[Ventricular_system|cerebral ventricle]]s due to [[hydrocephalus]] are also more common in Aicardi syndrome. | ||
===Diagnostic Criteria=== | |||
===History and Symptoms=== | |||
===Physical Examination=== | |||
===Laboratory Findings=== | |||
===Imaging Findings=== | |||
===Other Diagnostic Studies=== | |||
==Treatment== | ==Treatment== | ||
Treatment of Aicardi syndrome primarily involves management of [[seizures]] and early/continuing intervention programs for developmental delays. | Treatment of Aicardi syndrome primarily involves management of [[seizures]] and early/continuing intervention programs for developmental delays. | ||
Additional complications sometimes seen with Aicardi syndrome include [[porencephaly|porencephalic cyst]]s and [[hydrocephalus]], and gastro-intestinal problems. Treatment for prencephalic cysts and/or hydrocephalus is often via a [[cerebral shunt|shunt]] or [[endoscopic]] [[fenestration]] of the cysts, though some require no treatment. Placement of a [[feeding tube]], fundoplication, and surgeries to correct hernias or other gastrointestinal structural problems are sometimes used to treat gastro-intestinal issues. | Additional complications sometimes seen with Aicardi syndrome include [[porencephaly|porencephalic cyst]]s and [[hydrocephalus]], and gastro-intestinal problems. Treatment for prencephalic cysts and/or hydrocephalus is often via a [[cerebral shunt|shunt]] or [[endoscopic]] [[fenestration]] of the cysts, though some require no treatment. Placement of a [[feeding tube]], fundoplication, and surgeries to correct hernias or other gastrointestinal structural problems are sometimes used to treat gastro-intestinal issues. | ||
===Medical Therapy=== | |||
== | ===Surgery=== | ||
===Prevention=== | |||
==Support Organizations== | ==Support Organizations== | ||
Line 62: | Line 89: | ||
[http://www.sindromediaicardi.com/ Sindrome di Aicardi]<br /> | [http://www.sindromediaicardi.com/ Sindrome di Aicardi]<br /> | ||
==References== | |||
{{Reflist|2}} | |||
[[Category: | |||
[[Category:Neurology]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
Line 73: | Line 101: | ||
[[fi:Aicardin oireyhtymä]] | [[fi:Aicardin oireyhtymä]] | ||
{{WS}} | {{WS}} | ||
{{WH}} |
Revision as of 15:16, 2 August 2016
WikiDoc Resources for Aicardi syndrome |
Articles |
---|
Most recent articles on Aicardi syndrome Most cited articles on Aicardi syndrome |
Media |
Powerpoint slides on Aicardi syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Aicardi syndrome at Clinical Trials.gov Trial results on Aicardi syndrome Clinical Trials on Aicardi syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Aicardi syndrome NICE Guidance on Aicardi syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Aicardi syndrome Discussion groups on Aicardi syndrome Patient Handouts on Aicardi syndrome Directions to Hospitals Treating Aicardi syndrome Risk calculators and risk factors for Aicardi syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for Aicardi syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Template:DiseaseDisorder infobox
Overview
Aicardi syndrome is an uncommon malformation syndrome characterized by absence of a key structure in the brain called the corpus callosum, the presence of retinal abnormalities, and seizures in the form of infantile spasms. Aicardi syndrome is inherited as an X-linked dominant trait that is lethal in males.
Historical Perspective
This disorder was first recognized as a distinct syndrome in 1965 by Jean Aicardi, a French neurologist. A review article by Dr. Aicardi (Aicardi J, Aicardi syndrome: old and new findings, Int Pediatr. 1998;14(1):5-8) describes the syndrome. Aicardi syndrome should not be confused with Aicardi-Goutières syndrome, a distinct disorder.
Classification
Pathosphysiology
Genetics
Almost all reported cases of Aicardi syndrome have been in females. The few males that have been identified with Aicardi syndrome have proved to have 47 chromosomes including an XXY sex chromosome complement, a condition called Klinefelter syndrome.
Aicardi syndrome appears to be lethal in normal males who have only one X chromosome (and a Y chromosome). In other words, Aicardi syndrome appears to be inherited in an X-linked dominant pattern due to a mutant gene on the X chromosome that is lethal in XY males.
All cases of Aicardi syndrome are thought to be due to new mutations. No person with Aicardi syndrome is known to have transmited the X-linked gene responsible for the syndrome to the next generation.
Causes
Differentiating Aicardi syndrome from Other Diseases
Epidemiology and Demographics
Around 500 cases of Aicardi syndrome have been reported worldwide. Except that the syndrome is fairly uncommon, its precise frequency in the population is unknown. Almost all reported cases of Aicardi syndrome have been in females.
Risk Factors
Screening
Natural History, Complications, Prognosis
Children are most commonly identified with Aicardi syndrome between the ages of three and five months. A significant number of these girls are products of normal births and seem to be developing normally until around the age of three months, when they begin to have infantile spasms. The onset of infantile spasms at this age is due to closure of the final neural synapses in the brain, a stage of normal brain development.
Additional complications sometimes seen with Aicardi syndrome include porencephalic cysts and hydrocephalus, and gastro-intestinal problems.
The prognosis varies widely from case to case. However, all individuals reported with Aicardi syndrome to date have experienced developmental delay of a significant degree, typically resulting in moderate to profound mental retardation. The age range of the individuals reported with Aicardi syndrome is from birth to the mid 40’s. Aicardi syndrome appears to be lethal in normal males who have only one X chromosome (and a Y chromosome).
Diagnosis
Aicardi syndrome is characterized by the following triad of features:
- Partial or complete absence of the corpus callosum in the brain (agenesis of the corpus callosum);
- Eye abnormalities known as "lacunae" of the retina that are quite specific to this disorder; and
- The development in infancy of seizures that are called infantile spasms.
Other types of defects of the brain such as microcephaly, porencephalic cysts and enlarged cerebral ventricles due to hydrocephalus are also more common in Aicardi syndrome.
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Imaging Findings
Other Diagnostic Studies
Treatment
Treatment of Aicardi syndrome primarily involves management of seizures and early/continuing intervention programs for developmental delays. Additional complications sometimes seen with Aicardi syndrome include porencephalic cysts and hydrocephalus, and gastro-intestinal problems. Treatment for prencephalic cysts and/or hydrocephalus is often via a shunt or endoscopic fenestration of the cysts, though some require no treatment. Placement of a feeding tube, fundoplication, and surgeries to correct hernias or other gastrointestinal structural problems are sometimes used to treat gastro-intestinal issues.
Medical Therapy
Surgery
Prevention
Support Organizations
Aicardi Syndrome Foundation Support and information for families caring for children with Aicardi Syndrome.
A.A.L Syndrome d'Aicardi
Sindrome di Aicardi